Protara Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Protara Therapeutics, Inc. (TARA) reported Foreign Currency Transaction Gain (Loss), before Tax of $66.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-14.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2018-03-14
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2016-12-31 was -$53.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2016-09-30 was -$2.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2016-06-30 was -$63.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2016-03-31 was $184.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2016 was $66.00K.
- Protara Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2015 was -$589.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$55.00K derived: sum of 2 quarters · filed 2018-03-14 | -$118.00K derived: sum of 3 quarters · filed 2018-03-14 | $66.00K 10-K · filed 2018-03-14 |
| 2016-09-30 | -$2.00K 10-Q · filed 2017-11-07 | -$65.00K derived: sum of 2 quarters · filed 2017-11-07 | $119.00K 10-Q · filed 2017-11-07 | -$30.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$63.00K 10-Q · filed 2017-08-07 | $121.00K 10-Q · filed 2017-08-07 | -$28.00K derived: sum of 3 quarters · filed 2018-03-14 | -$342.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $184.00K 10-Q · filed 2017-05-10 | $35.00K derived: sum of 2 quarters · filed 2018-03-14 | -$279.00K derived: sum of 3 quarters · filed 2018-03-14 | -$405.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | -$149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$463.00K derived: sum of 2 quarters · filed 2018-03-14 | -$589.00K derived: sum of 3 quarters · filed 2018-03-14 | -$589.00K 10-K · filed 2018-03-14 |
| 2015-09-30 | -$314.00K 10-Q · filed 2016-11-07 | -$440.00K derived: sum of 2 quarters · filed 2016-11-07 | -$440.00K 10-Q · filed 2016-11-07 | |
| 2015-06-30 | -$126.00K 10-Q · filed 2016-08-08 | -$126.00K 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |